Citation: | LU Yun-qing, CAO Cheng, ZHENG Jia-ni, ZHU Zi-qiang, TONG Jia-xiang, QI Cheng-cheng, YUAN Lei, GUO Sheng, SU Shu-lan, KANG Hong-jie, DUAN Jin-ao, ZHU Yue. Effect Evaluation and Mechanism of Jujing Pills in Improving Retinal Injury in Subacute Aging Mice Induced by D-galactose[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(9): 849-859. doi: 10.14148/j.issn.1672-0482.2023.0849 |
[1] |
YANG K, LIANG YB, GAO LQ, et al. Prevalence of age-related macular degeneration in a rural Chinese population: The Handan Eye Study[J]. Ophthalmology, 2011, 118(7): 1395-1401. doi: 10.1016/j.ophtha.2010.12.030
|
[2] |
MITCHELL P, LIEW G, GOPINATH B, et al. Age-related macular degeneration[J]. Lancet, 2018, 392(10153): 1147-1159. doi: 10.1016/S0140-6736(18)31550-2
|
[3] |
XU TL, WANG BS, LIU H, et al. Prevalence and causes of vision loss in China from 1990 to 2019: Findings from the Global Burden of Disease Study 2019[J]. Lancet Publ Health, 2020, 5(12): e682-e691. doi: 10.1016/S2468-2667(20)30254-1
|
[4] |
林艳辉, 高莉茉, 姜文敏. 基于GBD数据库中国年龄相关性黄斑变性流行病学负担分析[J]. 中南大学学报(医学版), 2023, 48(1): 106-113. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYD202301012.htm
LIN YH, GAO LM, JIANG WM. Analysis of the epidemiological burden of age-related macular degeneration in China based on the data of global burden of disease[J]. J Cent South Univ Med Sci, 2023, 48(1): 106-113. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYD202301012.htm
|
[5] |
CONNOLLY E, RHATIGAN M, O'HALLORAN AM, et al. Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population[J]. Br J Ophthalmol, 2018, 102(12): 1691-1695. doi: 10.1136/bjophthalmol-2017-311673
|
[6] |
马洪梅, 孙凤海, 贾健. 视网膜色素上皮细胞的生理功能及其参与的病变[J]. 国际眼科杂志, 2015, 15(7): 1184-1186. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201507019.htm
MA HM, SUN FH, JIA J. Function and pathology of the retinal pigment epithelium[J]. Int Eye Sci, 2015, 15(7): 1184-1186. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201507019.htm
|
[7] |
FLAXEL CJ, ADELMAN RA, BAILEY ST, et al. Age-related macular degeneration preferred practice pattern[J]. Ophthalmology, 2020, 127(1): 1-65. doi: 10.1016/j.ophtha.2019.11.006
|
[8] |
陈晨凯, 王颖异, 曹程, 等. 年龄相关性黄斑变性的危险因素分析及对疾病动物模型构建的启示[J]. 中国现代应用药学, 2021, 38(15): 1894-1900. doi: 10.13748/j.cnki.issn1007-7693.2021.15.017
CHEN CK, WANG YY, CAO C, et al. Risk factors analysis of age-related macular degeneration and the enlightenment to the construction of disease animal models[J]. Chin J Mod Appl Pharm, 2021, 38(15): 1894-1900. doi: 10.13748/j.cnki.issn1007-7693.2021.15.017
|
[9] |
张敬法, 张宇萌, 孙晓东. 干性年龄相关性黄斑变性发病机制及治疗[J]. 眼科新进展, 2022, 42(3): 169-178. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ202203001.htm
ZHANG JF, ZHANG YM, SUN XD. Pathogenesis and treatment of dry age-related macular degeneration[J]. Recent Adv Ophthalmol, 2022, 42(3): 169-178. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ202203001.htm
|
[10] |
RICCI F, BANDELLO F, NAVARRA P, et al. Neovascular age-related macular degeneration: Therapeutic management and new-upcoming approaches[J]. Int J Mol Sci, 2020, 21(21): 8242. doi: 10.3390/ijms21218242
|
[11] |
GIL-MARTÍNEZ M, SANTOS-RAMOS P, FERNÁNDEZ-RODRíGUEZ M, et al. Pharmacological advances in the treatment of age-related macular degeneration[J]. Curr Med Chem, 2020, 27(4): 583-598.
|
[12] |
金明. AMD中医病因机制认识与现代研究相关性[J]. 中国中医眼科杂志, 2016, 26(3): 141-143. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGKZ201603003.htm
JIN M. Correlation between TCM etiology and mechanism of AMD and modern research[J]. China J Chin Ophthalmol, 2016, 26(3): 141-143. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGKZ201603003.htm
|
[13] |
太平惠民和剂局. 太平惠民和剂局方[M]. 北京: 人民卫生出版社, 1985: 249.
Taiping Imperial Pharmacy. Beneficial Formulas from the Taiping Imperial Pharmacy[M]. Beijing: People's medical publishing house, 1985: 249.
|
[14] |
洪晶, 张娅俐, 闫莎莎, 等. D-半乳糖诱导衰老小鼠模型研究进展[J]. 中国比较医学杂志, 2023, 33(3): 136-142. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGDX202303018.htm
HONG J, ZHANG YL, YAN SS, et al. Research progress of the D-galactose-induced aging mouse model[J]. Chin J Comp Med, 2023, 33(3): 136-142. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGDX202303018.htm
|
[15] |
王佳琪, 胡加亮, 徐寒梅. 衰老机制及抗衰老药物的研究进展[J]. 药学进展, 2023, 47(2): 154-160. https://www.cnki.com.cn/Article/CJFDTOTAL-YXJZ202302007.htm
WANG JQ, HU JL, XU HM. Mechanism of aging and anti-aging drug development[J]. Prog Pharm Sci, 2023, 47(2): 154-160. https://www.cnki.com.cn/Article/CJFDTOTAL-YXJZ202302007.htm
|
[16] |
HARMAN D. Aging: A theory based on free radical and radiation chemistry[J]. J Gerontol, 1956, 11(3): 298-300.
|
[17] |
ULLAH F, ALI T, ULLAH N, et al. Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain[J]. Neurochem Int, 2015, 90: 114-124.
|
[18] |
CHEW EY, CLEMONS TE, AGRÓN E, et al. Long-term outcomes of adding lutein/Zeaxanthin and ω-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28[J]. JAMA Ophthalmol, 2022, 140(7): 692-698.
|
[19] |
CHAN CM, HUANG DY, SEKAR P, et al. Reactive oxygen species-dependent mitochondrial dynamics and autophagy confer protective effects in retinal pigment epithelial cells against sodium iodate-induced cell death[J]. J Biomed Sci, 2019, 26(1): 40.
|
[20] |
张登本, 孙理军. 王冰医学全书[M]. 北京: 中国中医药出版社, 2006: 652.
ZHANG DB, SUN LJ. Medical Encyclopedia of Wang Bing[M]. Beijing: China press of traditional Chinese medicine, 2006: 652.
|
[21] |
赵佶敕. 圣济总录[M]. 北京: 人民卫生出版社, 2013: 1578.
ZHAO JC. Comprehensive Recording of Divine Assistance[M]. Beijing: People's medical publishing house, 2013: 1578.
|
[22] |
陈言. 三因极一病证方论[M]. 北京: 人民卫生出版社, 2023: 369.
CHEN Y. Treatise on Diseases, Patterns, and Formulas Related to the Unification of the Three Etiologies[M]. Beijing: People's medical publishing house, 2023: 369.
|
[23] |
杨宇. 杞菊地黄丸治疗飞蚊症肝肾阴虚证的疗效观察[J]. 基层中医药, 2022, 1(6): 56-60. https://www.cnki.com.cn/Article/CJFDTOTAL-JCEY202206013.htm
YANG Y. Observation on efficacy of Qiju Dihuang pills in treatment of floaters with liver and kidney Yin deficiency syndrome[J]. Basic Tradit Chin Med, 2022, 1(6): 56-60. https://www.cnki.com.cn/Article/CJFDTOTAL-JCEY202206013.htm
|
[24] |
MANTHEY AL, CHIU K, SO KF. Effects of Lycium barbarum on the visual system[J]. Int Rev Neurobiol, 2017, 135: 1-27.
|
[25] |
Research Group AREDS2. Lutein+Zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial[J]. JAMA, 2013, 309(19): 2005-2015.
|
[26] |
KIM J, JIN HL, JANG DS, et al. Quercetin-3-O-α-l-arabinopyranoside protects against retinal cell death via blue light-induced damage in human RPE cells and Balb-c mice[J]. Food Funct, 2018, 9(4): 2171-2183.
|
[27] |
郑慧丽. 基于网络药理学的枸杞子改善年龄相关性黄斑变性预测及验证分析[D]. 南京: 南京中医药大学, 2021.
ZHENG HL. Prediction and validation analysis of lycii fructus on improving age-related macular degeneration by network pharmacology[D]. Nanjing: Nanjing University of Chinese Medicine, 2021.
|
[28] |
黄清霞, 覃川娴, 何泽源, 等. 巴戟天化学成分、药理作用及质量标志物预测分析[J]. 中华中医药学刊, 2022, 40(7): 251-258. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202207061.htm
HUANG QX, QIN CX, HE ZY, et al. Chemical components and pharmacological action of bajitian(Radix morindae officinalis) and predictive analysis on Q-marker[J]. Chin Arch Tradit Chin Med, 2022, 40(7): 251-258. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202207061.htm
|
[29] |
周亚西, 周士琦, 冯朵, 等. 肉苁蓉生物活性成分及其免疫功效研究进展[J]. 食品科技, 2022, 47(6): 133-139. https://www.cnki.com.cn/Article/CJFDTOTAL-SSPJ202206019.htm
ZHOU YX, ZHOU SQ, FENG D, et al. Progress in understanding the bioactive components and immune efficacy of Cistanche[J]. Food Sci Technol, 2022, 47(6): 133-139. https://www.cnki.com.cn/Article/CJFDTOTAL-SSPJ202206019.htm
|